retatrutide clinical trial phase First 3 data for are here folks. This drug is a barn burner. This was only 68 weeks and was geared towards osteoarthritis of the knee. Massive pain improvements and Retatrutide FDA Approval Status: July
Description
Stubborn fat wont budge
Excluding GLP-1, pharma IRR drops from 5.9% to 3.8%
It is currently under investigation for obesity, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease (MASLD)
Purpose of Review Obesity affects over than 600 million adults worldwide resulting in multi-organ complications and major socioeconomic impact
Changes in urine habits can indicate health problems, such as a UTI, an STI, kidney problems, and diabetes.
This review discusses the clinical and physiological changes, and in particular, the mechanisms behind weight loss and glycaemic improvements, observed following the gastric bypass, sleeve gastrectomy and gastric banding bariatric procedures
